Hepatitis C Virus
Hepatitis C virus infection associated with increased risk of malignant lymphoma
Published in Hepatitis Weekly, September 20th, 2004
"Hepatitis C virus (HCV) has been implicated in the etiology of malignant lymphomas. We estimated the risk of lymphoma associated with detection of HCV infection. Cases (n=529) were consecutive patients newly diagnosed with a lymphoid malignancy between 1998 and 2002 in 4 centers in Spain," investigators in Spain report.
"Lymphomas were diagnosed and classified using the WHO Classification. Controls (n=600) were hospitalized patients matched to the cases by 5-year age group, gender and study center. Several medical conditions associated with severe...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-09-20)
More Articles from Hepatitis Weekly
- Adverse Drug Effects
Combination therapy for chronic hepatitis C may cause pancreatitis - Chronic Hepatitis B
HBV-positive kidneys merit prudent use in HBV-infected transplant recipients - Hepatology
CD8-1 is a reporter substrate for cells that harbor hepatitis C replication - Oncogenesis
RBMY gene expression associates with male liver cancer formation - Transplant Medicine
Pre-emptive antivirals aid living donor liver transplant recipients - Antiretroviral Therapy
HAART improves course of hepatitis C virus infection in HIV coinfected patients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
